Gastroresistant pharmaceutical formulations containing rifaximin

Details for Australian Patent Application No. 2006222206 (hide)

Owner Alfa Wassermann S.p.A.

Inventors Pantaleo, Maria Rosaria; Palazzini, Ernesto; Zamboni, Villiam; Viscomi, Giuseppe C.

Agent Lord and Company

Pub. Number AU-B-2006222206

PCT Pub. Number WO2006/094737

Priority BO 2005 A 000123 07.03.05 IT

Filing date 6 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 8 July 2010

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/094737 Priority application(s): WO2006/094737

8 July 2010 Application Accepted

  Published as AU-B-2006222206

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222213-Device for administering a breathing gas and method for adjusting breathing gas pressures that alternate at least in some phases

2006222204-Use of MGC4504